DENVER--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced results from a long-term study comparing SYMBICORT ® (budesonide/ formoterol fumarate dihydrate) Inhalation Aerosol 160/4.5 mcg with ...
Symbicort is an inhaler used for long-term control of asthma and COPD, but it is not a rescue inhaler. Before using Symbicort, tell your healthcare provider if you have health conditions like adrenal ...
SYMBICORT (Budesonide 160mcg, formoterol 4.5mcg) inhaler by AstraZeneca The FDA has approved Symbicort 160/4.5 micrograms (budesonide/formoterol fumarate dehydrate ...
LONDON (MarketWatch) -- Drugmaker AstraZeneca said Monday that the U.S. Food and Drug Administration has approved Symbicort 160/4.5 mcg for the twice daily maintenance treatment of airflow obstruction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results